Texas Statutes
Subchapter A. Prescription and Substitution Requirements
Section 562.012. Substitution of Dosage Form Permitted

Sec. 562.012. SUBSTITUTION OF DOSAGE FORM PERMITTED. With the patient's consent, a pharmacist may dispense a dosage form of a drug different from that prescribed, such as a tablet instead of a capsule or a liquid instead of a tablet, if the dosage form dispensed:
(1) contains the identical amount of the active ingredients as the dosage prescribed for the patient;
(2) is not an enteric-coated or timed release product; and
(3) does not alter desired clinical outcomes.
Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999.
Amended by:
Acts 2013, 83rd Leg., R.S., Ch. 583 (S.B. 869), Sec. 12, eff. June 14, 2013.

Structure Texas Statutes

Texas Statutes

Occupations Code

Title 3 - Health Professions

Subtitle J - Pharmacy and Pharmacists

Chapter 562 - Practice by License Holder

Subchapter A. Prescription and Substitution Requirements

Section 562.001. Definitions

Section 562.002. Legislative Intent

Section 562.003. Disclosure of Price; Patient's Option

Section 562.004. Prescription Transmitted Orally by Practitioner

Section 562.005. Record of Dispensed Drug or Biological Product

Section 562.0051. Communication Regarding Certain Dispensed Biological Products

Section 562.006. Label

Section 562.0061. Other Prescription Information

Section 562.0062. Required Statement Regarding Medication Disposal

Section 562.007. Refills

Section 562.008. Generic Equivalent or Interchangeable Biological Product Authorized

Section 562.009. Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product

Section 562.010. Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product; Liability

Section 562.011. Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product

Section 562.012. Substitution of Dosage Form Permitted

Section 562.013. Applicability of Subchapter

Section 562.014. Narrow Therapeutic Index Drugs

Section 562.0141. Transplant Immunosuppressant Drug Product Selection Prohibited

Section 562.0142. Adoption of Rules

Section 562.015. Dispensing Directive; Compliance With Federal Law

Section 562.016. List of Approved Interchangeable Biological Products